3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
2
Uveal Melanoma
1
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Sarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Pancreatic Neoplasms
1
Neurofibromatosis 2
1
Neoplasms, Mesothelial
1
Neoplasms
1
Mouth Neoplasms
1
Lymphangioleiomyomatosis
1
Erdheim-Chester Disease
1
Endocrine Gland Neoplasms
1
Disease Progression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Castleman Disease
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Interventions
Temozolomide
12
Specimen Handling
12
Magnetic Resonance Spectroscopy
12
Radiotherapy
8
Radiation
5
Surgical Procedures, Operative
3
Biopsy
3
trametinib
2
dabrafenib
2
Spinal Puncture
2
Radiotherapy, Intensity-Modulated
2
Genetic Therapy
2
Craniotomy
2
Bevacizumab
2
vorasidenib
1
vocimagene amiretrorepvec
1
veliparib
1
trastuzumab deruxtecan
1
tocilizumab
1
ribociclib
1
pembrolizumab
1
olutasidenib
1
atezolizumab
1
abexinostat
1
Vorinostat
1
Transurethral Resection of Bladder
1
Standard of Care
1
Restraint, Physical
1
Protons
1
Proton Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
Valproic Acid
×
90 days
×
Clear all
No trials found.